Ulrike W. Kaunzner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ulrike W. Kaunzner has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Amy Kuceyeski
Department of Radiology, Weill Cornell Medicine, New York, NY, USA
1 shared publication - Brittany Gerstein
Weill-Cornell-Medicine, Department of Neurology, 1305 York Avenue, New York City, 10021, USA
1 shared publication - Ceren Tozlu
Department of Radiology, Weill Cornell Medicine, New York, USA
1 shared publication - Keith Wakefield Jamison
Department of Radiology, Weill Cornell Medicine, New York, NY, USA
1 shared publication - Lauren Gluck
Montefiore Medical Center, 1250 Waters Place Tower 2, Bronx, NY 10461, USA
1 shared publication - Nancy E. Nealon
Department of Neurology, Weill-Cornell-Medicine, New York City, USA
1 shared publication
Latest Publications
- Open Access
- 9 May 2025
- Published by Elsevier in Neurotherapeutics
- Vol. 22 (4) , e00583
Repair mechanisms of the central nervous system: From axon sprouting to remyelination
- 9 May 2025
- Published by Elsevier in Neurotherapeutics
- Vol. 22 (4) , e00583
Open AccessRepair mechanisms of the central nervous system: From axon sprouting to remyelination
- 29 January 2025
- Published by Springer Nature in Current Pain and Headache Reports
- Vol. 29 (1) , 1-7
Pain and Headache in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
Purpose of Review The purpose of this review is to evaluate the current knowledge and recent findings on different pain and headache presentations associated with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) disease. Recent Findings MOGAD is an inflammatory autoimmune disease affecting mostly the central nervous system, presenting with optic neuritis, transverse myelitis and other forms of inflammatory demyelination. Pain and headache in MOGAD have been recognized more recently and acute and chronic forms of pain can occur in both the adult and pediatric population. An important recent observation is that MOGAD can affect the peripheral nervous system, which can contribute to pain symptoms. Summary Acute and chronic forms of pain have been described in MOGAD, including ocular pain, different types of headaches and neuropathies, involving the central and peripheral nervous system. Awareness of these types of pain in both the pediatric and adult population is crucial, to ensure timely diagnosis and treatment.
- 29 January 2025
- Published by Springer Nature in Current Pain and Headache Reports
- Vol. 29 (1) , 1-7
Pain and Headache in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
Purpose of Review The purpose of this review is to evaluate the current knowledge and recent findings on different pain and headache presentations associated with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) disease. Recent Findings MOGAD is an inflammatory autoimmune disease affecting mostly the central nervous system, presenting with optic neuritis, transverse myelitis and other forms of inflammatory demyelination. Pain and headache in MOGAD have been recognized more recently and acute and chronic forms of pain can occur in both the adult and pediatric population. An important recent observation is that MOGAD can affect the peripheral nervous system, which can contribute to pain symptoms. Summary Acute and chronic forms of pain have been described in MOGAD, including ocular pain, different types of headaches and neuropathies, involving the central and peripheral nervous system. Awareness of these types of pain in both the pediatric and adult population is crucial, to ensure timely diagnosis and treatment.
- Open Access
Structural disconnectivity from quantitative susceptibility mapping rim+ lesions is related to disability in people with multiple sclerosis
Background: Multiple Sclerosis (MS) is a disease characterized by inflammation, demyelination, and/or axonal loss that disrupts white matter pathways that constitute the brain’s structural connectivity network. Individual disease burden and disability in patients with MS (pwMS) varies widely across the population, possibly due to heterogeneity of lesion location, size and subsequent disruption of the structural connectome. Chronic active MS lesions, which have a hyperintense rim (rim+) on Quantitative Susceptibility Mapping (QSM) and a rim of iron-laden inflammatory cells, have been shown to be particularly detrimental to tissue concentration causing greater myelin damage compared to chronic silent MS lesions. How these rim+ lesions differentially impact structural connectivity and subsequently influence disability has not yet been explored. Objective: We characterize differences in the spatial location and structural disconnectivity patterns of rim+ lesions compared to rimlesions. We test the hypothesis that rim+ lesions’ disruption to the structural connectome are more predictive of disability compared to rimlesions’ disruption to the structural connectome. Finally, we quantify the most important regional structural connectome disruptions for disability prediction in pwMS. Methods: Ninety-six pwMS were included in our study (age: 40.25 ± 10.14, 67% female). Disability was assessed using Extended Disability Status Score (EDSS); thirty-seven pwMS had disability (EDSS ≥ 2). Regional structural disconnectivity patterns due to rim- and rim+ lesions were estimated using the Network Modification (NeMo) Tool. For each gray matter region, the NeMo Tool calculates a Change in Connectivity (ChaCo) score, i.e. the percent of connecting streamlines also passing through a lesion. Adaptive Boosting (ADA) classifiers were constructed based on demographics and the two sets of ChaCo scores (from rim+ and rim- lesions); performance was compared across the two models using the area under ROC curve (AUC). Finally, the importance of structural disconnectivity in each brain region in the disability prediction models was determined. Results: Rim+ lesions were much larger and tended to be more periventricular than rim- lesions. The model based on rim+ lesion structural disconnectivity measures had better disability classification performance (AUC = 0.67) than the model based on rim- lesion structural disconnectivity (AUC = 0.63). Structural disconnectivity, from both rim+ and rim- lesions, in the left thalamus and left cerebellum were most important for classifying pwMS into disability categories. Conclusion: Our findings suggest that, independent of the evidence that they have more damaging pathology, rim+ lesions also may be more influential on disability through their disruptions to the structural connectome. Furthermore, lesions of any type in the left cerebellum and left thalamus were especially important in classifying disability in pwMS. This analysis provides a deeper understanding of how lesion location/size and resulting disruption to the structural connectome can contribute to MS-related disability.
Open AccessStructural disconnectivity from quantitative susceptibility mapping rim+ lesions is related to disability in people with multiple sclerosis
Background: Multiple Sclerosis (MS) is a disease characterized by inflammation, demyelination, and/or axonal loss that disrupts white matter pathways that constitute the brain’s structural connectivity network. Individual disease burden and disability in patients with MS (pwMS) varies widely across the population, possibly due to heterogeneity of lesion location, size and subsequent disruption of the structural connectome. Chronic active MS lesions, which have a hyperintense rim (rim+) on Quantitative Susceptibility Mapping (QSM) and a rim of iron-laden inflammatory cells, have been shown to be particularly detrimental to tissue concentration causing greater myelin damage compared to chronic silent MS lesions. How these rim+ lesions differentially impact structural connectivity and subsequently influence disability has not yet been explored. Objective: We characterize differences in the spatial location and structural disconnectivity patterns of rim+ lesions compared to rimlesions. We test the hypothesis that rim+ lesions’ disruption to the structural connectome are more predictive of disability compared to rimlesions’ disruption to the structural connectome. Finally, we quantify the most important regional structural connectome disruptions for disability prediction in pwMS. Methods: Ninety-six pwMS were included in our study (age: 40.25 ± 10.14, 67% female). Disability was assessed using Extended Disability Status Score (EDSS); thirty-seven pwMS had disability (EDSS ≥ 2). Regional structural disconnectivity patterns due to rim- and rim+ lesions were estimated using the Network Modification (NeMo) Tool. For each gray matter region, the NeMo Tool calculates a Change in Connectivity (ChaCo) score, i.e. the percent of connecting streamlines also passing through a lesion. Adaptive Boosting (ADA) classifiers were constructed based on demographics and the two sets of ChaCo scores (from rim+ and rim- lesions); performance was compared across the two models using the area under ROC curve (AUC). Finally, the importance of structural disconnectivity in each brain region in the disability prediction models was determined. Results: Rim+ lesions were much larger and tended to be more periventricular than rim- lesions. The model based on rim+ lesion structural disconnectivity measures had better disability classification performance (AUC = 0.67) than the model based on rim- lesion structural disconnectivity (AUC = 0.63). Structural disconnectivity, from both rim+ and rim- lesions, in the left thalamus and left cerebellum were most important for classifying pwMS into disability categories. Conclusion: Our findings suggest that, independent of the evidence that they have more damaging pathology, rim+ lesions also may be more influential on disability through their disruptions to the structural connectome. Furthermore, lesions of any type in the left cerebellum and left thalamus were especially important in classifying disability in pwMS. This analysis provides a deeper understanding of how lesion location/size and resulting disruption to the structural connectome can contribute to MS-related disability.